Find a copy in the library
Finding libraries that hold this item...
|Description:||3635 pages : illustrations ; 29 cm|
|Contents:||Among the new drugs featured in this edition are: Nexium (esomeprazole magnesium), a new proton pump inhibitor approved for the treatment of GERD and H pylori eradication; Canasa (mesalamine), a new anti-inflammatory rectal suppository indicated for the treatment of active ulcerative proctitis; Lumigan (bimatoprost), a new ophthalmic solution approved for the reduction of elevated intraocular pressure associated with open angle glaucoma or ocular hypertension; Advair (fluticasone propionate/salmeterol xinafoate), a new combination inhalation powder approved for the maintenance treatment of asthma; Trizivir (abacavir sulfate/lamivudine/zidovudine), a new combination nucleoside analogue approved for the treatment of HIV-1 infection; Cancidas (caspofungin acetate), the first of a new class of antifungal agents called glucan synthesis inhibitors, is indicated for refractory treatment of invasive aspergillosis; Remeron SolTab (mirtazapine), a new orally disintegrating tablet for the treatment of depression; Lunelle Monthly (medroxyprogesterone acetate/estradiol cypionate), a new long acting contraceptive injection; Gleevec (imatinib mesylate), a new oral protein-tyrosine kinase inhibitor for the treatment of chronic myeloid leukaemia (CML); and Valcyte (valganciclovir HC1), the new antiviral prodrug of ganciclovir, is indicated for CMV retinitis in patients with AIDS.|
|Other Titles:||PDR 2002|